Brian Lin's profile photo

Brian Lin

Washington, D.C.

Editorial Director at EurekAlert!

@EurekAlert editorial director, lover of #arts, #scicomm and #DEI, RT's aren't endorsements. All views are my own. 🏳️‍🌈

Featured in: Favicon eurekalert.org Favicon wiley.com Favicon zdnet.com Favicon frontiersin.org Favicon ubc.ca Favicon seekingalpha.com Favicon jamanetwork.com Favicon cell.com Favicon science.org Favicon lareviewofbooks.org

Articles

  • Advancing ALS Through Gene Therapies, Early Intervention, and Multidisciplinary Care: Brian Lin, PhD

    3 weeks ago | neurologylive.com | Isabella Ciccone |Brian Lin

    CommentaryVideoMay 15, 2025Author(s):,Fact checked by:The research portfolio director at the Muscular Dystrophy Association discussed the evolving ALS therapeutic landscape, highlighting advances in genetic and RNA-based interventions.

  • NeuroVoices: Brian Lin, PhD, on Targeted Therapies and Biomarkers to Drive New Momentum in ALS Research

    1 month ago | neurologylive.com | Isabella Ciccone |Brian Lin

    Despite extensive research, amyotrophic lateral sclerosis (ALS) remains a progressive and fatal neurodegenerative disease with limited therapeutic options for patients living with the condition. One of the major challenges for the ALS field has been the incomplete understanding of the disease’s underlying biology, which has restricted the ability to target upstream mechanisms.

  • What you should know about ALS, also known as Lou Gehrig's disease

    1 month ago | medicalxpress.com | Brian Lin

    Amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig's Disease, based on the iconic 1930s New York Yankee baseball player—is a progressive neurodegenerative disease that affects thousands of Americans every year. ALS remains one of the most complex and challenging disorders known to science.

  • Gene-Targeted Therapies and Biomarkers Driving ALS Research Forward: Brian Lin, PhD

    1 month ago | neurologylive.com | Isabella Ciccone |Brian Lin

    WATCH TIME: 3 minutes“I think everyone in the field is really looking forward to seeing if some of the other genetically targeted therapies that are in the pipeline are going to be as successful as tofersen. We should really see those results coming up pretty soon.”Recent progress in gene and RNA-targeted therapies has possibly reshaped the therapeutic landscape for amyotrophic lateral sclerosis (ALS), particularly for patients with known genetic mutations.

  • What You Should Know About ALS, Also Known as Lou Gehrig’s Disease

    1 month ago | healthday.com | Brian Lin

    Published on: May 03, 2025, 1:30 pmUpdated on: May 03, 2025, 1:30 pmLoading content, please wait...

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
1K
Tweets
4K
DMs Open
Yes
Brian Lin
Brian Lin @brianlinworks
29 Jan 25

Reaching back into my @UBC #mediarelations days for some golden nuggets in this new @EurekAlert blogpost on creating a multi-faceted #scicomm campaign.

EurekAlert!
EurekAlert! @EurekAlert

Want to discover how to leverage @EurekAlert!’s diverse content types to develop a comprehensive #SciComm campaign?🌟 Read our latest blogpost here: https://t.co/i63jjPa0ts 1/6 #MarketingTips #ContentStrategy https://t.co/lVePYA9EJi

Brian Lin
Brian Lin @brianlinworks
29 Jan 25

RT @EurekAlert: Want to discover how to leverage @EurekAlert!’s diverse content types to develop a comprehensive #SciComm campaign?🌟 Read o…

Brian Lin
Brian Lin @brianlinworks
22 Nov 24

RT @LuzSpica: Aprendí y repasé mucho esta mañana en el taller que impartieron @brianlinworks, @lecteroide, @ggonzalitos y @ElAgusdeKomodo.…